Literature DB >> 15048135

Molecular mechanisms of apoptosis in the liver of rats after portal branch ligation with and without retrorsine.

Christian Picard1, Peter Starkel, Christine Sempoux, Alain Saliez, Valérie Lebrun, Yves Horsmans.   

Abstract

The mechanisms accounting for the atrophy of the portal blood-deprived liver lobes after portal branch ligation (PBL) are still unclear. The first aim of this study was to confirm the role of apoptosis in this process and to determine which apoptotic pathways are involved. The second aim of the study was to evaluate the effect of blocking compensatory hyperplasia of the nonligated lobes with retrorsine on the mechanisms of apoptosis in the ligated lobes. Mitochondrial Bax, Bcl-2 and Bcl-X(L), cytosolic cytochrome c, caspase-3, -8 and -9 activities and TNF-alpha levels were assessed in the liver of rats before and at various time points, ranging from 30 min to 7 days, after PBL. Caspase activities were also measured in rats pretreated with retrorsine. Both the mitochondrial and the death receptor-mediated pathways are activated in the ligated liver lobes after portal branch ligation. Caspase activation is inhibited by retrorsine pretreatment, resulting in fewer apoptotic bodies. Apoptosis accounts for the atrophy of the ligated lobes after PBL. It is inhibited by retrorsine, suggesting an attempt to reduce the loss of liver mass when hyperplasia of the nonligated lobes is impaired

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048135     DOI: 10.1038/labinvest.3700085

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  3 in total

1.  Impact of biomarkers expression before and after portal vein embolization on recurrence after two-stage hepatectomy for colorectal liver metastases.

Authors:  Masato Narita; Elie Oussoultzoglou; Marie-Pierre Chenard; Pascal Fuchshuber; Edoardo Rosso; Patrick Pessaux; Daniel Jaeck; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2011-11-29       Impact factor: 3.452

2.  Tumoral response and tumoral phenotypic changes in a rat model of diethylnitrosamine-induced hepatocellular carcinoma after salirasib and sorafenib administration.

Authors:  Olga Ciccarelli; Arthur Colson; Christine De Saeger; Raymond Reding; Christine Sempoux; Isabelle A Leclercq; Peter Stärkel
Journal:  Onco Targets Ther       Date:  2018-10-17       Impact factor: 4.147

3.  Size of portally deprived liver lobe after portal vein ligation and additional partial hepatectomy: Result of balancing proliferation and apoptosis.

Authors:  Weiwei Wei; Chuanfeng Hua; Tianjiao Zhang; Olaf Dirsch; Felix Gremse; André Homeyer; Utz Settmacher; Uta Dahmen
Journal:  Sci Rep       Date:  2020-03-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.